Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Bimatoprost Ocular Insert in Glaucoma/OHT (Extension)
NCT02143843Phase 2Completed
- Sponsor
- ForSight VISION5
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bimatoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by ForSight VISION5. Started Jun 2014; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02143843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143843.